These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36140839)

  • 21. Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis.
    Bojesen KB; Broberg BV; Fagerlund B; Jessen K; Thomas MB; Sigvard A; Tangmose K; Nielsen MØ; Andersen GS; Larsson HBW; Edden RAE; Rostrup E; Glenthøj BY
    Biol Psychiatry; 2021 Feb; 89(3):278-287. PubMed ID: 32928500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
    Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
    Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olfactory deficits and psychosis-spectrum symptoms in 22q11.2 deletion syndrome.
    Tang SX; Moberg PJ; Yi JJ; Wiemken AS; Dress EM; Moore TM; Calkins ME; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE; Turetsky BI
    Schizophr Res; 2018 Dec; 202():113-119. PubMed ID: 30007867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of striatal dopamine D
    Veselinović T; Vernaleken I; Janouschek H; Cumming P; Paulzen M; Mottaghy FM; Gründer G
    Psychopharmacology (Berl); 2018 Aug; 235(8):2221-2232. PubMed ID: 29717334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered glutamate level and its association with working memory among patients with treatment-resistant schizophrenia (TRS): a proton magnetic resonance spectroscopy study.
    Huang LC; Lin SH; Tseng HH; Chen KC; Abdullah M; Yang YK
    Psychol Med; 2023 May; 53(7):3220-3227. PubMed ID: 35197141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excitatory/Inhibitory Imbalance Underlies Hippocampal Atrophy in Individuals With 22q11.2 Deletion Syndrome With Psychotic Symptoms.
    Mancini V; Saleh MG; Delavari F; Bagautdinova J; Eliez S
    Biol Psychiatry; 2023 Oct; 94(7):569-579. PubMed ID: 37011759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study.
    Schaer M; Debbané M; Bach Cuadra M; Ottet MC; Glaser B; Thiran JP; Eliez S
    Schizophr Res; 2009 Dec; 115(2-3):182-90. PubMed ID: 19836927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Social cognition dysfunction in adolescents with 22q11.2 deletion syndrome (velo-cardio-facial syndrome): relationship with executive functioning and social competence/functioning.
    Campbell LE; McCabe KL; Melville JL; Strutt PA; Schall U
    J Intellect Disabil Res; 2015 Sep; 59(9):845-59. PubMed ID: 25726953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.
    Bakker G; Caan MW; Vingerhoets WA; da Silva-Alves F; de Koning M; Boot E; Nieman DH; de Haan L; Bloemen OJ; Booij J; van Amelsvoort TA
    PLoS One; 2016; 11(11):e0159928. PubMed ID: 27828960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
    Egerton A; Murphy A; Donocik J; Anton A; Barker GJ; Collier T; Deakin B; Drake R; Eliasson E; Emsley R; Gregory CJ; Griffiths K; Kapur S; Kassoumeri L; Knight L; Lambe EJB; Lawrie SM; Lees J; Lewis S; Lythgoe DJ; Matthews J; McGuire P; McNamee L; Semple S; Shaw AD; Singh KD; Stockton-Powdrell C; Talbot PS; Veronese M; Wagner E; Walters JTR; Williams SR; MacCabe JH; Howes OD
    Schizophr Bull; 2021 Mar; 47(2):505-516. PubMed ID: 32910150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical functional connectivity in resting-state networks of individuals with 22q11.2 deletion syndrome: associations with neurocognitive and psychiatric functioning.
    Mattiaccio LM; Coman IL; Schreiner MJ; Antshel KM; Fremont WP; Bearden CE; Kates WR
    J Neurodev Disord; 2016; 8():2. PubMed ID: 26855683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study.
    Abdallah CG; Hannestad J; Mason GF; Holmes SE; DellaGioia N; Sanacora G; Jiang L; Matuskey D; Satodiya R; Gasparini F; Lin X; Javitch J; Planeta B; Nabulsi N; Carson RE; Esterlis I
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Jul; 2(5):449-456. PubMed ID: 28993818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Exploratory Study of Spectroscopic Glutamatergic Correlates of Cortical Excitability in Depressed Adolescents.
    Lewis CP; Port JD; Frye MA; Vande Voort JL; Ameis SH; Husain MM; Daskalakis ZJ; Croarkin PE
    Front Neural Circuits; 2016; 10():98. PubMed ID: 27965544
    [No Abstract]   [Full Text] [Related]  

  • 34. Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis.
    Bakker G; Caan MW; Schluter RS; Bloemen OJ; da Silva-Alves F; de Koning MB; Boot E; Vingerhoets WA; Nieman DH; de Haan L; Booij J; van Amelsvoort TA
    Psychol Med; 2016 Aug; 46(11):2299-311. PubMed ID: 27193339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
    Sun D; Ching CRK; Lin A; Forsyth JK; Kushan L; Vajdi A; Jalbrzikowski M; Hansen L; Villalon-Reina JE; Qu X; Jonas RK; van Amelsvoort T; Bakker G; Kates WR; Antshel KM; Fremont W; Campbell LE; McCabe KL; Daly E; Gudbrandsen M; Murphy CM; Murphy D; Craig M; Vorstman J; Fiksinski A; Koops S; Ruparel K; Roalf DR; Gur RE; Schmitt JE; Simon TJ; Goodrich-Hunsaker NJ; Durdle CA; Bassett AS; Chow EWC; Butcher NJ; Vila-Rodriguez F; Doherty J; Cunningham A; van den Bree MBM; Linden DEJ; Moss H; Owen MJ; Murphy KC; McDonald-McGinn DM; Emanuel B; van Erp TGM; Turner JA; Thompson PM; Bearden CE
    Mol Psychiatry; 2020 Aug; 25(8):1822-1834. PubMed ID: 29895892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced amplitude and slowed latency of the acoustic startle response in adolescents and adults with 22q11.2 deletion syndrome.
    Parker DA; Imes S; Ruban G; Ousley OY; Henshey B; Massa NM; Walker E; Cubells JF; Duncan E
    Schizophr Res; 2024 Jul; 269():9-17. PubMed ID: 38703519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered cortical thickness development in 22q11.2 deletion syndrome and association with psychotic symptoms.
    Bagautdinova J; Zöller D; Schaer M; Padula MC; Mancini V; Schneider M; Eliez S
    Mol Psychiatry; 2021 Dec; 26(12):7671-7678. PubMed ID: 34253864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocannabinoid levels in plasma and neurotransmitters in the brain: a preliminary report on patients with a psychotic disorder and healthy individuals.
    van Hooijdonk CFM; Balvers MGJ; van der Pluijm M; Smith CLC; de Haan L; Schrantee A; Yaqub M; Witkamp RF; van de Giessen E; van Amelsvoort TAMJ; Booij J; Selten JP
    Psychol Med; 2024 Jul; 54(9):2189-2199. PubMed ID: 38389452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.
    Moore CM; Biederman J; Wozniak J; Mick E; Aleardi M; Wardrop M; Dougherty M; Harpold T; Hammerness P; Randall E; Lyoo IK; Renshaw PF
    J Affect Disord; 2007 Apr; 99(1-3):19-25. PubMed ID: 17005256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo brain endocannabinoid metabolism is related to hippocampus glutamate and structure - a multimodal imaging study with PET,
    Watts JJ; Guma E; Chavez S; Tyndale RF; Ross RA; Houle S; Wilson AA; Chakravarty M; Rusjan PM; Mizrahi R
    Neuropsychopharmacology; 2022 Oct; 47(11):1984-1991. PubMed ID: 35906490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.